Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Epstein-Barr virus nuclear antigen 3A promotes cellular proliferation by repression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1.

Tursiella ML, Bowman ER, Wanzeck KC, Throm RE, Liao J, Zhu J, Sample CE.

PLoS Pathog. 2014 Oct 2;10(10):e1004415. doi: 10.1371/journal.ppat.1004415. eCollection 2014 Oct.

2.

Macrophage/epithelial cell CCL2 contributes to rhinovirus-induced hyperresponsiveness and inflammation in a mouse model of allergic airways disease.

Schneider D, Hong JY, Bowman ER, Chung Y, Nagarkar DR, McHenry CL, Goldsmith AM, Bentley JK, Lewis TC, Hershenson MB.

Am J Physiol Lung Cell Mol Physiol. 2013 Feb 1;304(3):L162-9. doi: 10.1152/ajplung.00182.2012. Epub 2012 Nov 30.

3.

Neonatal rhinovirus infection induces mucous metaplasia and airways hyperresponsiveness.

Schneider D, Hong JY, Popova AP, Bowman ER, Linn MJ, McLean AM, Zhao Y, Sonstein J, Bentley JK, Weinberg JB, Lukacs NW, Curtis JL, Sajjan US, Hershenson MB.

J Immunol. 2012 Mar 15;188(6):2894-904. doi: 10.4049/jimmunol.1101391. Epub 2012 Feb 13.

4.

MDA5 and TLR3 initiate pro-inflammatory signaling pathways leading to rhinovirus-induced airways inflammation and hyperresponsiveness.

Wang Q, Miller DJ, Bowman ER, Nagarkar DR, Schneider D, Zhao Y, Linn MJ, Goldsmith AM, Bentley JK, Sajjan US, Hershenson MB.

PLoS Pathog. 2011 May;7(5):e1002070. doi: 10.1371/journal.ppat.1002070. Epub 2011 May 26.

5.

Rhinovirus infection of allergen-sensitized and -challenged mice induces eotaxin release from functionally polarized macrophages.

Nagarkar DR, Bowman ER, Schneider D, Wang Q, Shim J, Zhao Y, Linn MJ, McHenry CL, Gosangi B, Bentley JK, Tsai WC, Sajjan US, Lukacs NW, Hershenson MB.

J Immunol. 2010 Aug 15;185(4):2525-35. doi: 10.4049/jimmunol.1000286. Epub 2010 Jul 19.

6.

Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses.

Wang Q, Nagarkar DR, Bowman ER, Schneider D, Gosangi B, Lei J, Zhao Y, McHenry CL, Burgens RV, Miller DJ, Sajjan U, Hershenson MB.

J Immunol. 2009 Dec 1;183(11):6989-97. doi: 10.4049/jimmunol.0901386. Epub 2009 Nov 4.

7.
8.

Discriminative stimulus, reinforcing, physical dependence, and antinociceptive effects of oxycodone in mice, rats, and rhesus monkeys.

Beardsley PM, Aceto MD, Cook CD, Bowman ER, Newman JL, Harris LS.

Exp Clin Psychopharmacol. 2004 Aug;12(3):163-72.

PMID:
15301633
9.

N-(trifluoromethyl)benzyl substituted N-normetazocines and N-norketobemidones.

May EL, Coop A, Woods JH, Aceto MD, Bowman ER, Harris LS, Traynor JR.

Bioorg Med Chem. 2003 Jan 2;11(1):31-3.

PMID:
12467704
10.

Synthesis and in vitro and in vivo activity of (-)-(1R,5R,9R)- and (+)-(1S,5S,9S)-N-alkenyl-, -N-alkynyl-, and -N-cyanoalkyl-5, 9-dimethyl-2'-hydroxy-6,7-benzomorphan homologues.

May EL, Jacobson AE, Mattson MV, Traynor JR, Woods JH, Harris LS, Bowman ER, Aceto MD.

J Med Chem. 2000 Dec 28;43(26):5030-6.

PMID:
11150174
11.

3-Alkyl ethers of clocinnamox: delayed long-term mu-antagonists with variable mu efficacy.

Husbands SM, Sadd J, Broadbear JH, Woods JH, Martin J, Traynor JR, Aceto MD, Bowman ER, Harris LS, Lewis JW.

J Med Chem. 1998 Aug 27;41(18):3493-8.

PMID:
9719602
12.

Dependence studies of new compounds in the rhesus monkey, rat and mouse (1997).

Aceto MD, Bowman ER, Harris LS, May EL.

NIDA Res Monogr. 1998 Mar;178:363-407. No abstract available.

PMID:
9686404
13.

Etorphines: mu-opioid receptor-selective antinociception and low physical dependence capacity.

Aceto MD, Harris LS, Bowman ER.

Eur J Pharmacol. 1997 Nov 12;338(3):215-23.

PMID:
9424015
14.

Cocaine, ecgonine methyl ester, and benzoylecgonine plasma profiles in rhesus monkeys.

Saady JJ, Bowman ER, Aceto MD.

J Anal Toxicol. 1995 Nov-Dec;19(7):571-5.

PMID:
8577180
15.

Antipodal alpha-N-(methyl through decyl)-N-normetazocines (5,9 alpha-dimethyl-2'-hydroxy-6,7-benzomorphans): in vitro and in vivo properties.

May EL, Aceto MD, Bowman ER, Bentley C, Martin BR, Harris LS, Medzihradsky F, Mattson MV, Jacobson AE.

J Med Chem. 1994 Sep 30;37(20):3408-18.

PMID:
7932569
17.

Dependence studies of new compounds in the rhesus monkey, rat and mouse (1993).

Aceto MD, Bowman ER, Harris LS, May EL.

NIDA Res Monogr. 1994;140:103-78. No abstract available.

PMID:
8722464
18.

Cocaine-induced rausch: overt behaviour and plasma concentrations in rhesus monkeys.

Saady JJ, Bowman ER, Aceto MD.

Eur J Drug Metab Pharmacokinet. 1994 Jan-Mar;19(1):41-6.

PMID:
7957451
19.

Nicotine's opioid and anti-opioid interactions: proposed role in smoking behavior.

Aceto MD, Scates SM, Ji Z, Bowman ER.

Eur J Pharmacol. 1993 Dec 1;248(4):333-5.

PMID:
8181540
20.
21.

Dependence studies of new compounds in the rhesus monkey, rat and mouse (1992).

Aceto MD, Bowman ER, Harris LS, May EL.

NIDA Res Monogr. 1993;132:459-516. Review. No abstract available.

PMID:
8341373
22.

Central behavioral interactions between ethanol, (-)-nicotine, and (-)-cotinine in mice.

Dar MS, Li C, Bowman ER.

Brain Res Bull. 1993;32(1):23-8.

PMID:
8319100
23.

Blockade of dynorphin A(1-13) overt psychomotor effects by naloxone.

Aceto MD, Bowman ER.

Peptides. 1992 Jul-Aug;13(4):847-9.

PMID:
1359510
24.

Dependence studies of new compounds in the rhesus monkey and mouse (1991).

Aceto MD, Bowman ER, Harris LS, May EL.

NIDA Res Monogr. 1992;119:513-58. Review. No abstract available.

PMID:
1435984
25.

Dependence studies of new compounds in the rhesus monkey and mouse (1990).

Aceto MD, Bowman ER, Harris LS, May EL.

NIDA Res Monogr. 1990;105:640-81. Review.

PMID:
1876150
26.

Common stereospecificity of opioid and dopamine systems for N-butyrophenone prodine-like compounds.

Iorio MA, Frigeni V, Bowman ER, Harris LS, May EL, Aceto MD.

J Med Chem. 1991 Jan;34(1):194-7.

PMID:
1671414
27.

Very long-acting narcotic antagonists: the 14 beta-p-substituted cinnamoylaminomorphinones and their partial mu agonist codeinone relatives.

Aceto MD, Bowman ER, May EL, Harris LS, Woods JH, Smith CB, Medzihradsky F, Jacobson AE.

Arzneimittelforschung. 1989 May;39(5):570-5.

PMID:
2547389
28.

Dependence studies on new compounds in the rhesus monkey, rat and mouse (1989).

Aceto MD, Bowman ER, Harris LS, May EL.

NIDA Res Monogr. 1989;95:578-631. No abstract available.

PMID:
2641054
29.

Plasma concentrations of nicotine in rats during tolerance and chronic exposure studies.

Thomas BF, Bowman ER, Tucker SM, Aceto MD.

Eur J Drug Metab Pharmacokinet. 1988 Oct-Dec;13(4):247-52.

PMID:
3243318
30.

Dependence studies of new compounds in the rhesus monkey, rat and mouse (1986).

Aceto MD, Bowman ER, Harris LS, May EL.

NIDA Res Monogr. 1987;76:392-447. No abstract available.

PMID:
3125467
31.

Tissue disposition of [3H]sarin and its metabolites in mice.

Little PJ, Reynolds ML, Bowman ER, Martin BR.

Toxicol Appl Pharmacol. 1986 May;83(3):412-9.

PMID:
3705071
32.

Comparison of the ability of opioid analgesics to increase endogenous opioid-like activity in the cerebrospinal fluid of rabbits.

Kachur JF, Rosemond R, Welch S, Bowman ER, Martin BR, Brase DA, Dewey WL.

Life Sci. 1985 Dec 30;37(26):2549-55.

PMID:
4079662
33.

In vivo mammalian metabolism of methylamine and methylurea and their metabolic interrelationship.

Dar MS, Bowman ER.

Drug Metab Dispos. 1985 Nov-Dec;13(6):682-9.

PMID:
2867871
34.

The enzymatic systems involved in the mammalian metabolism of methylamine.

Dar MS, Morselli PL, Bowman ER.

Gen Pharmacol. 1985;16(6):557-60.

PMID:
2867948
35.

Synthesis and preliminary binding studies of 4,4-ditritio-(-)-nicotine of high specific activity.

Vincek WC, Martin BR, Aceto MD, Bowman ER.

J Med Chem. 1980 Aug;23(8):960-2.

PMID:
7401120
36.

Nicotine antibodies: comparison of ligand specificities of antibodies produced against two nicotine conjugates.

Castro A, Monji N, Ali H, Yi JM, Bowman ER, McKennis H Jr.

Eur J Biochem. 1980 Mar;104(2):331-40.

37.

Automated radioimmunoassay of nicotine.

Castro A, Monji N, Malkus H, Eisenhart W, McKennis H Jr, Bowman ER.

Clin Chim Acta. 1979 Aug 1;95(3):473-81.

PMID:
487585
38.

The interrelationship between the metabolism of (S)-continine-N-oxide and (S)-cotinine.

Yi JM, Sprouse CT, Bowman ER, McKennis H Jr.

Drug Metab Dispos. 1977 Jul-Aug;5(4):355-62.

PMID:
19214
39.

Nicotine-like actions of cis-metanicotine and trans-metanicotine.

Wilson KL Jr, Chang RS, Bowman ER, McKennis H Jr.

J Pharmacol Exp Ther. 1976 Mar;196(3):685-96.

PMID:
1263119
40.

Possible alternate routes in the metabolism of betahistine in the rabbit.

Bowman FJ, Bowman ER, McKennis H Jr.

Proc Soc Exp Biol Med. 1972 Sep;140(4):1385-8. No abstract available.

PMID:
4626937
41.

Additional routes in the metabolism of nicotine to 3-pyridylacetate. The metabolism of dihydrometanicotine.

Meacham RH Jr, Bowman ER, McKennis H Jr.

J Biol Chem. 1972 Feb 10;247(3):902-8. No abstract available.

42.

Betahistine, its metabolites and vascular responses in the forelimb of the dog.

Konzett H, Bost RG, Bowman FJ, Bowman ER, McKennis H Jr.

J Pharmacol Exp Ther. 1971 Jul;178(1):122-9. No abstract available.

PMID:
4996589
43.

Effects of some nicotine metabolites and related compounds on isolated smooth muscle.

Kim KS, Borzelleca JF, Bowman ER, McKennis H Jr.

J Pharmacol Exp Ther. 1968 May;161(1):59-69. No abstract available.

PMID:
4231101
44.

Metabolism of (plus or minus)-cotinine-2-14C in the rat.

Morselli PL, Ong HH, Bowman ER, McKennis H Jr.

J Med Chem. 1967 Nov;10(6):1033-6. No abstract available.

PMID:
6056027
45.

Urinary excretion of conjugate forms of 1-(3-pyridyl)ethanol after administration of 3-acetylpyridine.

McKennis H Jr, Turnbull LB, Bowman ER, Lukhard CN.

J Biol Chem. 1966 Apr 25;241(8):1878-81. No abstract available.

46.

THE METABOLIC FORMATION OF GAMMA-(3-PYRIDYL)-GAMMA-HYDROXYBUTYRIC ACID AND ITS POSSIBLE INTERMEDIARY ROLE IN THE MAMMALIAN METABOLISM OF NICOTINE.

MCKENNIS H Jr, SCHWARTZ SL, TURNBULL LB, TAMAKI E, BOWMAN ER.

J Biol Chem. 1964 Nov;239:3981-9. No abstract available.

47.

ALTERNATE ROUTES IN THE METABOLIC DEGRADATION OF THE PYRROLIDINE RING OF NICOTINE.

MCKENNIS H Jr, SCHWARTZ SL, BOWMAN ER.

J Biol Chem. 1964 Nov;239:3990-6. No abstract available.

48.

METABOLIC RELEASE OF METHYL GROUPS FROM A SERIES OF N-METHYLPYRIDINIUM COMPOUNDS.

MCKENNIS H Jr, BOWMAN ER, HORVATH A, BEDERKA JP Jr.

Nature. 1964 May 16;202:699-700. No abstract available.

PMID:
14190039
49.

ADDITIONAL ROUTES IN THE METABOLISM OF 3-ACETYLPYRIDINE.

MCKENNIS H Jr, TURNBULL LB, BOWMAN ER.

J Biol Chem. 1964 Apr;239:1215-20. No abstract available.

50.

DISPOSITION AND FATE OF (--)-COTININE-H3 IN THE MOUSE.

BOWMAN ER, HANSSON E, TURNBULL LB, MCKENNIS H Jr, SCHMITERLOEW CG.

J Pharmacol Exp Ther. 1964 Mar;143:301-8. No abstract available.

PMID:
14161140

Supplemental Content

Loading ...
Support Center